Movalsys participates in the REINFORCE project, a collective effort by Aldakin, Naitec, NNBI 2020, Eversens, Clínica Universidad de Navarra, Cistec and Movalsys, which seeks to develop an Artificial Intelligent platform for the prediction of the cancer toxicity and the cancer recurrence. 
Whithin the framework of this project, subsidiced by the Gorvenment of Navarre in the Call for Strategic Projects 2020, Movalsis has been carrying out measurements at the Clínica Universidad de Navarra on oncologic patiente in the last weeks. The purpouse of these measurements is to obtain an objective assessment of its degree of frailty, as well as a whole set of biomechanical variables that will serve to feed the mathematical model that will predict the toxicity of the treatments and the probability of cancer recurrence.


Escribir comentario

Comentarios: 0